Oneview Healthcare (ASX:ONE) ROCE %: -81.60% (As of Dec. 2025)

What is Oneview Healthcare ROCE %?

Oneview Healthcare ASX:ONE -9.68% 42 ROCE % is -81.60% as of Dec. 2025. GuruFocus rates ASX:ONE with a GF Score™ of 42/100 and a GF Value™ of A$0.33 (Possible Value Trap). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Oneview Healthcare's annualized ROCE % for the quarter that ended in Dec. 2025 was -81.60%.

Oneview Healthcare (ASX:ONE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Oneview Healthcare ROCE % Related Terms

Oneview Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Oneview Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oneview Healthcare ROCE % Chart

Oneview Healthcare Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-98.02

-132.08

-108.53

-82.12

-107.06

Oneview Healthcare Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROCE %	Get a 7-Day Free Trial															-126.77	-120.43	-85.48	-128.46	-81.60

42GF Score

Oneview Healthcare PLC ASX:ONE

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Oneview Healthcare ROCE % Calculation

Oneview Healthcare's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-19.366	/	( ( (42.919 - 16.736)	+	(27.286 - 17.29) )	/ 2 )
	=	-19.366	/	( (26.183	+	9.996)	/ 2 )
	=	-19.366	/	18.0895
	=	-107.06 %

Oneview Healthcare's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	-11.064	/	( ( (28.61 - 11.489)	+	(27.286 - 17.29) )	/ 2 )
	=	-11.064	/	( ( 17.121	+	9.996 )	/ 2 )
	=	-11.064	/	13.5585
	=	-81.60 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -81.60% mean?

Oneview Healthcare (ASX:ONE) has a ROCE % of -81.60% as of Dec. 2025.

Is Oneview Healthcare's ROCE % too high?

Oneview Healthcare's current ROCE % is -81.60%. Overall, Oneview Healthcare has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Oneview Healthcare's ROCE % compare to VEEV and BTSG?

Oneview Healthcare's ROCE % of -81.60% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneview Healthcare's current ROCE % is -81.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Oneview Healthcare stock overvalued right now?

Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.14 — trading 57.6% below its estimated fair value. The current ROCE % is -81.60%. Oneview Healthcare's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current ROCE % is -81.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?

Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued. The current stock price of A$0.14 is trading 57.6% below its estimated GF Value™ of A$0.33. GuruFocus considers Oneview Healthcare to be Possible Value Trap.

Key valuation signals for ASX:ONE:

ROCE %: -81.60%
GF Value™: A$0.33 vs. price of A$0.14 (57.6% below fair value)
GF Score™: 42/100 with 5 warning signs

No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oneview Healthcare Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies ASX:ALC ASX:BB1 ASX:PHX ASX:M7T ASX:SHG ASX:EMD ASX:PCK ASX:TRI ASX:BMT ASX:PKY VEEV BTSG ASX:PME TEM HQY TSE:2413 HKSE:02228 HNGE DOCS WAY

Address Temple Road, 2nd Floor, Avoca Court, Blackrock Co, Dublin, IRL, A94 R7W3

Website https://www.oneviewhealthcare.com

Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.

42GF Score

Get the complete analysis for ASX:ONE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.14

Price

A$0.33

GF Value

View ASX:ONE Analysis

See ROCE % data for all stocks →